The ESMO 2017 Congress, in partnership with the European Association for Cancer Research (EACR), will bring cancer researchers and clinicians together to enable collaboration and the exchange of ideas, from the laboratory to the bedside and back. This exciting partnership creates a unique cancer congress in Europe with huge scientific reach and the true potential to improve the lives of cancer patients.
The ESMO Congress is the most influential annual meeting for oncology professionals in Europe. We invite you to save the date.
Basic science Biomarkers
Breast cancer, early stage
Breast cancer, locally advanced
Breast cancer, metastatic
CNS tumours
Developmental therapeutics
Endocrine tumours
Gastrointestinal tumours, colorectal Gastrointestinal tumours, non-colorectal
Genitourinary tumours, prostate
Genitourinary tumours, non-prostate
Gynaecological cancers
Haematological malignancies
Head and neck cancer, excluding thyroid
Health economics
Immunotherapy of cancer
Melanoma and other skin tumours
Neuroendocrine tumours
New diagnostic tools
NSCLC, early stage
NSCLC, locally advanced
NSCLC, metastatic
Palliative care
Prevention and screening
Psycho-oncology
Public health
Sarcoma
SCLC
Supportive care
Thoracic malignancies, other
Translational research
Tumour biology and pathology
Thyroid cancer
Miscellaneous
09月06日
2017
09月12日
2017
注册截止日期
留言